Zydus receives USFDA’s approvals for Pimavanserin Capsules, 34 mg and Pimavanserin Tablets,10 mg
Pimavanserin is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis
Pimavanserin is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis
This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients
The Institute is catering the health needs of the surrounding population with ever-increasing OPD every year along with special OPDs like mother & Child OPD, and LSD clinic
Subscribe To Our Newsletter & Stay Updated